Oxygenta Pharmaceutical Balance Sheet Annual

BSE: 524636 | NSE: - | ISIN: INE102E01018 | Sector: Biotechnology & Drugs

74.80 +1.70 (2.33%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.10	0.11	0.16	0.45
Cashand Short Term Investments	0.10	0.11	0.16	0.45
Accounts Receivable- Trade Net	7.36	10.16	1.58	1.61
Total Receivables Net	7.36	10.16	1.58	1.65
Total Inventory	13.72	11.71	7.28	12.11
Other Current Assets Total	2.93	3.04	0.55	1.74
Total Current Assets	24.11	25.01	9.56	15.94
Property/ Plant/ Equipment Total- Net	29.36	27.91	20.32	16.97
Long Term Investments	0.05	0.05	0.05	0.05
Note Receivable- Long Term	0.95	1.30	1.24	0.91
Other Long Term Assets Total	8.73	0.00	-	-
Total Assets	63.19	54.26	31.18	33.86
Accounts Payable	22.89	23.78	6.46	13.79
Notes Payable/ Short Term Debt	8.23	4.97	1.09	2.85
Other Currentliabilities Total	2.58	1.07	0.52	2.20
Total Current Liabilities	33.70	29.82	8.07	18.84
Long Term Debt	49.00	63.02	51.04	45.04
Total Long Term Debt	49.00	63.02	51.04	45.04
Total Debt	57.23	67.99	52.13	47.89
Other Liabilities Total	0.62	5.97	5.23	8.01
Total Liabilities	83.31	100.46	65.81	71.88
Common Stock Total	33.48	14.20	14.20	10.20
Other Equity Total	-53.61	-60.40	-48.83	-48.22
Total Equity	-20.12	-46.20	-34.63	-38.02
Total Liabilities Shareholders' Equity	63.19	54.26	31.18	33.86
Total Common Shares Outstanding	3.35	1.42	1.42	1.02
Tangible Book Valueper Share Common Eq	-6.01	-32.53	-24.38	-37.27
Current Portof LT Debt/ Capital Leases	-	0.00	0.00	-
Capital Lease Obligations	-	0.00	0.00	-
Deferred Income Tax	-	1.66	1.46	-